Acadian Asset Management
GTHX

Acadian Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Acadian Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-928,205
Closed -$2.11M – 2401
2024
Q2 		$2.11M Buy
928,205
+494,496
+114% +$1.89M 0.01% 743
2024
Q1 		$1.87M Buy
433,709
+375,354
+643% +$1.31M 0.01% 674
2023
Q4 		$177K Sell
58,355
-73,230
-56% -$138K ﹤0.01% 1256
2023
Q3 		$189K Buy
+131,585
New +$255K ﹤0.01% 1200
2023
Q1 		– Sell
-30,475
Closed -$165K – 2016
2022
Q4 		$165K Buy
+30,475
New +$255K ﹤0.01% 1332
2020
Q2 		– Sell
-5,876
Closed -$65K – 2366
2020
Q1 		$65K Buy
+5,876
New +$110K ﹤0.01% 1452
2019
Q2 		– Sell
-18,371
Closed -$305K – 2082
2019
Q1 		$305K Buy
+18,371
New +$348K ﹤0.01% 1246

Acadian Asset Management's GTHX Position: Q3 2024 in Review

Acadian Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 928,205 shares — an estimated $2.11M sold.

Acadian Asset Management first reported a position in GTHX in Q1 2019 and held it in 7 quarters. The position peaked at $2.11M in Q2 2024. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Acadian Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Acadian Asset Management sold 928,205 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $2.11M.
  • Acadian Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • Acadian Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $2.11M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Acadian Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.